Title: Medical Controlled Substances Transportation Act of 2022
Policy area: Crime and Law Enforcement

Summary:
Medical Controlled Substances Transportation Act of 2022
This bill allows health care practitioners who are already registered by the Drug Enforcement Administration to dispense certain controlled substances to also obtain a separate registration that allows them to temporarily transport and administer these substances in other states in which they are not registered.

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7259 Introduced in House (IH)]

<DOC>






117th CONGRESS
  2d Session
                                H. R. 7259

 To amend the Controlled Substances Act to direct the Attorney General 
to register practitioners to transport controlled substances to States 
   in which the practitioner is not registered under the Act for the 
purpose of administering the substances (under applicable State law) at 
   locations other than principal places of business or professional 
                               practice.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 28, 2022

 Mr. Sessions introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend the Controlled Substances Act to direct the Attorney General 
to register practitioners to transport controlled substances to States 
   in which the practitioner is not registered under the Act for the 
purpose of administering the substances (under applicable State law) at 
   locations other than principal places of business or professional 
                               practice.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medical Controlled Substances 
Transportation Act of 2022''.

SEC. 2. REGISTRATION FOR TRANSPORT OF CONTROLLED SUBSTANCES TO STATES 
              IN WHICH THE PRACTITIONER IS NOT REGISTERED UNDER THE 
              CONTROLLED SUBSTANCES ACT FOR THE PURPOSE OF 
              ADMINISTERING THE SUBSTANCES AT LOCATIONS OTHER THAN 
              PRINCIPAL PLACES OF BUSINESS OR PROFESSIONAL PRACTICE.

    Section 303 of the Controlled Substances Act (21 U.S.C. 823) is 
amended by adding at the end the following:
    ``(l) Registration for Transport of Controlled Substances to States 
in Which the Practitioner Is Not Registered for the Purpose of 
Administering the Substances at Locations Other Than Principal Places 
of Business or Professional Practice.--
            ``(1) In general.--Upon application by a practitioner 
        (other than a pharmacy) who is registered under subsection (f), 
        the Attorney General shall issue a separate registration to the 
        practitioner authorizing the practitioner--
                    ``(A) to transport one or more controlled 
                substances in schedule II, III, IV, or V from the 
                practitioner's registered location in a State to one or 
                more States in which the practitioner is not registered 
                under subsection (f) for the purpose of the 
                practitioner administering the substances at locations 
                other than a principal place of business or 
                professional practice; and
                    ``(B) to so administer the substances.
            ``(2) Requirements.--For a practitioner to be authorized to 
        transport and administer controlled substances pursuant to a 
        registration issued under paragraph (1), all of the following 
        conditions must be satisfied:
                    ``(A) The practitioner must be licensed, 
                registered, or otherwise permitted by the State in 
                which the controlled substances are administered to 
                carry out such activity at the location where it 
                occurs.
                    ``(B) The practitioner must--
                            ``(i) limit the time of transport and 
                        administering of any controlled substance 
                        pursuant to such registration to not more than 
                        72 consecutive hours; and
                            ``(ii) by the conclusion of such 72 hours, 
                        return any such controlled substance so 
                        transported but not administered to the 
                        registered location from which such substance 
                        was obtained.
                    ``(C)(i) The practitioner must maintain records of 
                the transporting and administering of any controlled 
                substance pursuant to this subsection.
                    ``(ii) Such records shall be maintained, in 
                accordance with the requirements of section 307(b), at 
                the practitioner's registered location from which the 
                controlled substances were obtained and shall include--
                            ``(I) the location where the controlled 
                        substance was administered; and
                            ``(II) such other information as may be 
                        required by regulation of the Attorney General 
                        with respect to records for dispensers of 
                        controlled substances.
                    ``(iii) Notwithstanding clause (ii), the exception 
                in subsection 307(c)(1)(B) shall not apply to records 
                required by this subparagraph.
            ``(3) Grounds for denial or revocation.--The Attorney 
        General may deny an application for registration under this 
        subsection, or a renewal thereof, or revoke such registration, 
        based on the criteria listed in section 304(a), except that the 
        applicant shall not be required, as a condition of initially 
        obtaining such registration, to present proof of State 
        authorization to administer controlled substances.
            ``(4) Automatic termination.--A registration issued under 
        this subsection shall automatically terminate if the 
        practitioner no longer has an active registration under 
        subsection (f) due to revocation, suspension, surrender, or 
        other termination.
            ``(5) Definition.--In this subsection, the term `registered 
        location' means, with respect to each registration issued to a 
        practitioner under subsection (f), the address that appears on 
        the certificate of registration.''.
                                 <all>